Sepsis caused by Enterobacter

Sepsis caused by Enterobacter is a life-threatening, dysregulated host systemic inflammatory response to an invasive bloodstream or focal tissue infection by opportunistic Gram-negative bacilli of the genus Enterobacter It predominantly affects hospitalized individuals, critically ill patients in intensive care units, immunocompromised populations, and neonates, frequently originating from indwelling vascular catheters, the urinary tract, the respiratory system, or intra-abdominal sources

Sepsis caused by Enterobacter is a life-threatening, dysregulated host systemic inflammatory response to an invasive bloodstream or focal tissue infection by opportunistic Gram-negative bacilli of the genus Enterobacter Pathophysiologically, bacterial endotoxins trigger widespread endothelial injury, microvascular permeability, and cytokine release, manifesting clinically with fever or hypothermia, tachycardia, tachypnea, hypotension, and acute multi-organ dysfunction

Sepsis caused by Enterobacter is a life-threatening, dysregulated host systemic inflammatory response to an invasive bloodstream or focal tissue infection by opportunistic Gram-negative bacilli of the genus Enterobacter Pathophysiologically, bacterial endotoxins trigger widespread endothelial injury, microvascular permeability, and cytokine release, manifesting clinically with fever or hypothermia, tachycardia, tachypnea, hypotension, and acute multi-organ dysfunction

It predominantly affects hospitalized individuals, critically ill patients in intensive care units, immunocompromised populations, and neonates, frequently originating from indwelling vascular catheters, the urinary tract, the respiratory system, or intra-abdominal sources

It predominantly affects hospitalized individuals, critically ill patients in intensive care units, immunocompromised populations, and neonates, frequently originating from indwelling vascular catheters, the urinary tract, the respiratory system, or intra-abdominal sources Management is clinically challenging due to the frequent presence of inducible chromosomal AmpC beta-lactamases and acquired extended-spectrum resistance mechanisms that narrow antimicrobial efficacy

It predominantly affects hospitalized individuals, critically ill patients in intensive care units, immunocompromised populations, and neonates, frequently originating from indwelling vascular catheters, the urinary tract, the respiratory system, or intra-abdominal sources